Assyro AI

FDA Orange Book · active-ingredient family

Acetaminophen; caffeine; dihydrocodeine bitartrate

Acetaminophen; caffeine; dihydrocodeine bitartrate is approved in 9 FDA applications, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.

0

Brand (NDA)

9

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Generic (ANDA) products (9)

ProductApplicantApplicationTEApproved
ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATEPHARMOBEDIENTANDA 204209Sep 30, 2016
TREZIXKEY THERAPANDA 204785Nov 26, 2014
ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATEWRASER PHARMS LLCANDA 040688Apr 03, 2007
ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATEBOCA PHARMA LLCANDA 040701Apr 03, 2007
ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATEWEST-WARD PHARM CORPANDA 040637Sep 22, 2006
ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATEMIKARTANDA 040316Apr 28, 1999
ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATEMIKARTANDA 040109Aug 26, 1997
SYNALGOS-DC-ALEITNER PHARMSANDA 089166May 14, 1986
DHC PLUSPHARM RES ASSOCANDA 088584Mar 04, 1986

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Acetaminophen; caffeine; dihydrocodeine bitartrate — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.